Published in Obesity and Diabetes Week, December 19th, 2005
"Patients with diabetes mellitus are at increased risk for repeat interventions and mortality, after coronary angioplasty and stenting. The efficacy of sirolimus-eluting stents (SESs)to improve the outcomes of these patients is a focus of interest," investigators in the United States report.
P.K. Kuchulakanti and colleagues at the Washington Hospital Center found, "In the first 1,407 patients treated with SESs at our institution, 492 were diabetic (insulin dependent diabetes mellitus [IDDM], n=160 and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.